🔎 Trials Near Me

Domov › Rak dojke › Texas › The Woodlands

Klinične študije za Rak dojke v The Woodlands, TX

10 študij za Rak dojke išče udeležence na lokacijah v The Woodlands in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Vključevanje udeležencevFaza 3
  • US Oncology Research Network, The Woodlands
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07174336

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Vključevanje udeležencevFaza 3
  • Renovatio Clinical, The Woodlands
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05894239

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Vključevanje udeležencevFaza 3
  • Renovatio Clinical - The Woodlands Research Center, The Woodlands
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07173751

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Vključevanje udeležencevFaza 3
  • Research Site, Kingwood · 20 mi stran
Starost 18–130 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07647328

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Vključevanje udeležencevFaza 3
  • Community Clinical Trials, Spring · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06790693

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Vključevanje udeležencevFaza 3
  • Houston Methodist The Woodlands Hospital, The Woodlands
  • UT MD Anderson - The Woodlands, Conroe · 11 mi stran
Starost 18–60 · Ženske · Posodobljeno 2. sep. 2026 · NCT05879926

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Vključevanje udeležencevFaza 2
  • Community Clinical Trials, Kingwood · 20 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06764940

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1
  • The University of Texas MD Anderson Cancer Center - Conroe, Conroe · 11 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07318805

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Vključevanje udeležencevFaza 3
  • Houston Methodist The Woodlands Hospital, The Woodlands
  • MD Anderson in The Woodlands, Conroe · 11 mi stran
Starost 50–70 · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT04852887

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

Vključevanje udeležencevOpazovalna študija
  • MD Anderson in The Woodlands, The Woodlands
Starost 18 in več · Vsi spoli · Posodobljeno 15. apr. 2026 · NCT00477100

Študije za Rak dojke v drugih mestih

Druge študije v The Woodlands

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.